Amrutanjan Health Care Ltd vs Kabra Drugs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Amrutanjan Health Care Ltd is ₹ 548.1 as of 06 May 15:30 . The P/E Ratio of Amrutanjan Health Care Ltd changed from 27.1 on March 2021 to 36.7 on March 2025 . This represents a CAGR of 6.25% over 5 yearsThe P/E Ratio of Kabra Drugs Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Amrutanjan Health Care Ltd changed from ₹ 1661 crore on March 2021 to ₹ 1864 crore on March 2025 . This represents a CAGR of 2.34% over 5 yearsThe Market Cap of Kabra Drugs Ltd changed from ₹ 2 crore on March 2022 to ₹ 26.27 crore on March 2025 . This represents a CAGR of 90.37% over 4 years The revenue of Amrutanjan Health Care Ltd for the Dec '25 is ₹ 145.16 crore as compare to the Sep '25 revenue of ₹ 122 crore. This represent the growth of 18.98% The revenue of Kabra Drugs Ltd for the Dec '25 is ₹ 30.6 crore as compare to the Sep '25 revenue of ₹ 19.94 crore. This represent the growth of 53.46% The ebitda of Amrutanjan Health Care Ltd for the Dec '25 is ₹ 28.04 crore as compare to the Sep '25 ebitda of ₹ 20.82 crore. This represent the growth of 34.68% The ebitda of Kabra Drugs Ltd for the Dec '25 is ₹ 2.62 crore as compare to the Sep '25 ebitda of ₹ 2.22 crore. This represent the growth of 18.02% The net profit of Amrutanjan Health Care Ltd changed from ₹ 4.62 crore to ₹ 19.45 crore over 7 quarters. This represents a CAGR of 127.37% The net profit of Kabra Drugs Ltd changed from ₹ -0.55 crore to ₹ 2.57 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Amrutanjan Health Care Ltd changed from 20.04 % on March 2021 to 26.15 % on March 2025 . This represents a CAGR of 5.47% over 5 yearsThe Dividend Payout of Kabra Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Amrutanjan Health Care Ltd

Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu.
The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on in-house research.
Three plants have been set up in the Alandur industrial belt near Chennai to produce these products.
It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore.
Pheromones have found wide application as pesticides and are used on cotton crops.

About Kabra Drugs Ltd

Kabra Drugs Limited was incorporated as a Limited Company on August 22, 1989.
The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical.
The commercial production commenced in 1991.
Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products.
The Company has 500+ products across India. The Company was incorporated with a mission to enrich the lives through pharmaceutical solutions which are innovative, high-quality and accessible to every family it serves.

FAQs for the comparison of Amrutanjan Health Care Ltd and Kabra Drugs Ltd

Which company has a larger market capitalization, Amrutanjan Health Care Ltd or Kabra Drugs Ltd?

Market cap of Amrutanjan Health Care Ltd is 1,584 Cr while Market cap of Kabra Drugs Ltd is 62 Cr

What are the key factors driving the stock performance of Amrutanjan Health Care Ltd and Kabra Drugs Ltd?

The stock performance of Amrutanjan Health Care Ltd and Kabra Drugs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amrutanjan Health Care Ltd and Kabra Drugs Ltd?

As of May 6, 2026, the Amrutanjan Health Care Ltd stock price is INR ₹548.1. On the other hand, Kabra Drugs Ltd stock price is INR ₹26.21.

How do dividend payouts of Amrutanjan Health Care Ltd and Kabra Drugs Ltd compare?

To compare the dividend payouts of Amrutanjan Health Care Ltd and Kabra Drugs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.